General Information of Drug Transporter (DT)
DT ID DTD0071 Transporter Info
Gene Name ABCG1
Transporter Name ATP-binding cassette sub-family G member 1
Gene ID
9619
UniProt ID
P45844
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM)

Chemical Compound

  DT Modulation1

T0901317 co-treated with Alitretinoin results in increased expression of ABCG1 mRNA [53]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Estradiol co-treated with Progesterone results in decreased expression of ABCG1 mRNA [70]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Progesterone results in increased expression of ABCG1 mRNA [80]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

PPARG mutant form inhibits the reaction Telmisartan results in increased expression of ABCG1 mRNA [9]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Valproic Acid affects the expression of ABCG1 mRNA [90]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Valproic Acid affects the methylation of ABCG1 gene [21]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Estradiol co-treated with Progesterone results in decreased expression of ABCG1 mRNA [70]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Estradiol co-treated with TGFB1 protein results in increased expression of ABCG1 mRNA [71]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Cisplatin affects the expression of ABCG1 mRNA [10]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

IGF1 protein inhibits the reaction Ethanol results in decreased expression of ABCG1 mRNA [42]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

IGF1 protein inhibits the reaction Ethanol results in decreased expression of ABCG1 protein [42]

Regulation Mechanism

Transcription Factor Info

  DT Modulation1

Benzo(a)pyrene affects the methylation of ABCG1 intron [52]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Benzo(a)pyrene affects the methylation of ABCG1 promoter [56]

Regulation Mechanism

Transcription Factor Info

  1,2-linoleoylphosphatidylcholine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

1,2-linoleoylphosphatidylcholine results in decreased expression of ABCG1 protein [47]

Regulation Mechanism

Transcription Factor Info

  2,2',4,4'-tetrabromodiphenyl ether

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ABCG1 mRNA [48]

Regulation Mechanism

Transcription Factor Info

  22-hydroxycholesterol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

22-hydroxycholesterol results in increased expression of ABCG1 mRNA [4]

Regulation Mechanism

Transcription Factor Info

  2,3-bis(3'-hydroxybenzyl)butyrolactone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABCG1 mRNA [49]

Regulation Mechanism

Transcription Factor Info

  24-hydroxycholesterol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

24-hydroxycholesterol results in increased expression of ABCG1 protein [32]

Regulation Mechanism

Transcription Factor Info

  8-Bromo Cyclic Adenosine Monophosphate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of ABCG1 mRNA [50]

Regulation Mechanism

Transcription Factor Info

  afimoxifene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

afimoxifene inhibits the reaction Estrogens results in decreased expression of ABCG1 mRNA [51]

Regulation Mechanism

Transcription Factor Info

  Amphotericin B

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Amphotericin B analog results in decreased expression of ABCG1 mRNA [54]

Regulation Mechanism

Transcription Factor Info

  Arachidonic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Arachidonic Acid results in decreased expression of ABCG1 mRNA [4]

Regulation Mechanism

Transcription Factor Info

  beauvericin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

beauvericin co-treated with enniatins results in decreased expression of ABCG1 mRNA [55]

Regulation Mechanism

Transcription Factor Info

  benzo(e)pyrene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

benzo(e)pyrene results in increased methylation of ABCG1 intron [52]

Regulation Mechanism

Transcription Factor Info

  bisphenol A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bisphenol A results in decreased methylation of ABCG1 gene [57]

Regulation Mechanism

Transcription Factor Info

  bis(tri-n-butyltin)oxide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

bis(tri-n-butyltin)oxide results in increased expression of ABCG1 mRNA [58]

Regulation Mechanism

Transcription Factor Info

  Cadmium Chloride

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cadmium Chloride results in increased abundance of Cadmium which results in increased expression of ABCG1 mRNA [59]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Cadmium Chloride results in increased expression of ABCG1 mRNA [60]

Regulation Mechanism

Transcription Factor Info

  CGP 52608

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CGP 52608 promotes the reaction RORA protein binds to ABCG1 gene [61]

Regulation Mechanism

Transcription Factor Info

  Chenodeoxycholic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCG1 mRNA [62]

Regulation Mechanism

Transcription Factor Info

  chloroacetaldehyde

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

chloroacetaldehyde results in decreased expression of ABCG1 mRNA [12]

Regulation Mechanism

Transcription Factor Info

  Cholesterol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Resveratrol results in increased expression of ABCG1 protein which results in increased secretion of Cholesterol [63]

Regulation Mechanism

Transcription Factor Info

  clothianidin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

clothianidin results in decreased expression of ABCG1 mRNA [38]

Regulation Mechanism

Transcription Factor Info

  Copper

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Disulfiram binds to Copper which results in increased expression of ABCG1 mRNA [64]

Regulation Mechanism

Transcription Factor Info

  cordycepin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cordycepin results in increased expression of ABCG1 mRNA [65]

Regulation Mechanism

Transcription Factor Info

  Coumestrol

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABCG1 mRNA [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Coumestrol co-treated with Resveratrol results in decreased expression of ABCG1 mRNA [49]

Regulation Mechanism

Transcription Factor Info

  cypermethrin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

cypermethrin results in decreased expression of ABCG1 mRNA [34]

Regulation Mechanism

Transcription Factor Info

  Deoxycholic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCG1 mRNA [62]

Regulation Mechanism

Transcription Factor Info

  Dichlorodiphenyl Dichloroethylene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dichlorodiphenyl Dichloroethylene results in decreased expression of ABCG1 mRNA [66]

Regulation Mechanism

Transcription Factor Info

  di-n-butylphosphoric acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

di-n-butylphosphoric acid affects the expression of ABCG1 mRNA [67]

Regulation Mechanism

Transcription Factor Info

  Disulfiram

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Disulfiram binds to Copper which results in increased expression of ABCG1 mRNA [64]

Regulation Mechanism

Transcription Factor Info

  Diuron

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Diuron results in decreased expression of ABCG1 mRNA [68]

Regulation Mechanism

Transcription Factor Info

  Docetaxel

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ABCG1 gene SNP affects the susceptibility to Docetaxel [69]

Regulation Mechanism

Transcription Factor Info

  Eicosapentaenoic Acid

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Eicosapentaenoic Acid results in decreased expression of ABCG1 mRNA [4]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Eicosapentaenoic Acid results in decreased expression of ABCG1 protein [4]

Regulation Mechanism

Transcription Factor Info

  enniatins

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

beauvericin co-treated with enniatins results in decreased expression of ABCG1 mRNA [55]

Regulation Mechanism

Transcription Factor Info

  entinostat

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

entinostat results in increased expression of ABCG1 mRNA [35]

Regulation Mechanism

Transcription Factor Info

  epigallocatechin gallate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

epigallocatechin gallate results in decreased expression of ABCG1 mRNA [3]

Regulation Mechanism

Transcription Factor Info

  Estrogens

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

afimoxifene inhibits the reaction Estrogens results in decreased expression of ABCG1 mRNA [51]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Estrogens results in decreased expression of ABCG1 mRNA [51]

Regulation Mechanism

Transcription Factor Info

  fatostatin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CGA protein inhibits the reaction fatostatin promotes the reaction T0901317 results in increased expression of ABCG1 mRNA [72]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

fatostatin promotes the reaction T0901317 results in increased expression of ABCG1 mRNA [72]

Regulation Mechanism

Transcription Factor Info

  Glycochenodeoxycholic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCG1 mRNA [62]

Regulation Mechanism

Transcription Factor Info

  Glycocholic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCG1 mRNA [62]

Regulation Mechanism

Transcription Factor Info

  Glycodeoxycholic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt co-treated with Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid results in increased expression of ABCG1 mRNA [62]

Regulation Mechanism

Transcription Factor Info

  GW 3965

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GW 3965 inhibits the reaction Nicotine results in decreased expression of ABCG1 mRNA [18]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

GW 3965 inhibits the reaction Nicotine results in decreased expression of ABCG1 protein [18]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

GW 3965 results in increased expression of ABCG1 mRNA [73]

Regulation Mechanism

Transcription Factor Info

  Hexachlorocyclohexane

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Hexachlorocyclohexane results in increased expression of ABCG1 mRNA [11]

Regulation Mechanism

Transcription Factor Info

  lly-283

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

lly-283 results in increased expression of ABCG1 mRNA [74]

Regulation Mechanism

Transcription Factor Info

  Methapyrilene

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Methapyrilene results in increased methylation of ABCG1 intron [52]

Regulation Mechanism

Transcription Factor Info

  nickel chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

nickel chloride results in increased expression of ABCG1 mRNA [31]

Regulation Mechanism

Transcription Factor Info

  Nicotine

           6 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GW 3965 inhibits the reaction Nicotine results in decreased expression of ABCG1 mRNA [18]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

GW 3965 inhibits the reaction Nicotine results in decreased expression of ABCG1 protein [18]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Nicotine results in decreased expression of ABCG1 mRNA [18]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Nicotine results in decreased expression of ABCG1 protein [18]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Vecuronium Bromide inhibits the reaction Nicotine results in decreased expression of ABCG1 mRNA [18]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Vecuronium Bromide inhibits the reaction Nicotine results in decreased expression of ABCG1 protein [18]

Regulation Mechanism

Transcription Factor Info

  obeticholic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

obeticholic acid results in decreased expression of ABCG1 mRNA [14]

Regulation Mechanism

Transcription Factor Info

  Okadaic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Okadaic Acid results in increased expression of ABCG1 mRNA [76]

Regulation Mechanism

Transcription Factor Info

  Oxygen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Oxygen deficiency results in decreased expression of ABCG1 mRNA [12]

Regulation Mechanism

Transcription Factor Info

  Ozone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ozone inhibits the reaction T0901317 results in increased expression of ABCG1 mRNA [77]

Regulation Mechanism

Transcription Factor Info

  perfluorooctane sulfonic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

perfluorooctane sulfonic acid results in increased expression of ABCG1 mRNA [22]

Regulation Mechanism

Transcription Factor Info

  perfluorooctanoic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

perfluorooctanoic acid results in increased expression of ABCG1 mRNA [78]

Regulation Mechanism

Transcription Factor Info

  pirinixic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

pirinixic acid binds to and results in increased activity of PPARA protein which results in decreased expression of ABCG1 mRNA [79]

Regulation Mechanism

Transcription Factor Info

  potassium perchlorate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

potassium perchlorate results in decreased expression of ABCG1 mRNA [16]

Regulation Mechanism

Transcription Factor Info

  quinocetone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

quinocetone results in increased expression of ABCG1 mRNA [81]

Regulation Mechanism

Transcription Factor Info

  Silicon Dioxide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Silicon Dioxide analog results in decreased expression of ABCG1 mRNA [85]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Silicon Dioxide results in decreased expression of ABCG1 mRNA [86]

Regulation Mechanism

Transcription Factor Info

  stearic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

stearic acid results in increased expression of ABCG1 mRNA [4]

Regulation Mechanism

Transcription Factor Info

  Succimer

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Succimer co-treated with Magnetite Nanoparticles results in decreased expression of ABCG1 mRNA [87]

Regulation Mechanism

Transcription Factor Info

  T0901317

           8 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CGA protein inhibits the reaction fatostatin promotes the reaction T0901317 results in increased expression of ABCG1 mRNA [72]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

CGA protein inhibits the reaction T0901317 results in increased expression of ABCG1 mRNA [72]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

fatostatin promotes the reaction T0901317 results in increased expression of ABCG1 mRNA [72]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Ozone inhibits the reaction T0901317 results in increased expression of ABCG1 mRNA [77]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

T0901317 co-treated with Alitretinoin results in increased expression of ABCG1 mRNA [53]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

T0901317 results in increased expression of ABCG1 mRNA [53]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

T0901317 results in increased expression of ABCG1 protein [20]

Regulation Mechanism

Transcription Factor Info

  DT Modulation8

triphenyl phosphate inhibits the reaction T0901317 results in increased expression of ABCG1 mRNA [88]

Regulation Mechanism

Transcription Factor Info

  triadimefon

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

triadimefon results in increased expression of ABCG1 mRNA [36]

Regulation Mechanism

Transcription Factor Info

  tributyltin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tributyltin results in increased expression of ABCG1 mRNA [58]

Regulation Mechanism

Transcription Factor Info

  trichostatin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

trichostatin A results in decreased expression of ABCG1 mRNA [36]

Regulation Mechanism

Transcription Factor Info

  triphenyl phosphate

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

triphenyl phosphate affects the expression of ABCG1 mRNA [67]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

triphenyl phosphate inhibits the reaction T0901317 results in increased expression of ABCG1 mRNA [88]

Regulation Mechanism

Transcription Factor Info

  urushiol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

urushiol results in increased expression of ABCG1 mRNA [89]

Regulation Mechanism

Transcription Factor Info

  Vecuronium Bromide

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vecuronium Bromide inhibits the reaction Nicotine results in decreased expression of ABCG1 mRNA [18]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

Vecuronium Bromide inhibits the reaction Nicotine results in decreased expression of ABCG1 protein [18]

Regulation Mechanism

Transcription Factor Info

  Vincristine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Vincristine results in decreased susceptibility to Vincristine which results in decreased expression of ABCG1 mRNA [91]

Regulation Mechanism

Transcription Factor Info

  ZM 241385

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ZM 241385 inhibits the reaction Resveratrol results in increased expression of ABCG1 protein [82]

Regulation Mechanism

Transcription Factor Info

Approved Drug

  Rosiglitazone

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rosiglitazone increases the expression of ABCG1 [1]

Regulation Mechanism

via enhancement of Peroxisome proliferator-activated receptor gamma (PPARG) Transcription Factor Info

Cell System

C57BL/6J alveolar macrophages

  Raloxifene Hydrochloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Raloxifene Hydrochloride affects the expression of ABCG1 [2]

  Acetylcysteine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acetylcysteine inhibits the expression of ABCG1 [3]

  Alitretinoin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Alitretinoin increases the expression of ABCG1 [4]

  Clozapine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clozapine increases the expression of ABCG1 [5]

  Rosuvastatin Calcium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rosuvastatin Calcium inhibits the expression of ABCG1 [6]

  Simvastatin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Simvastatin inhibits the expression of ABCG1 [7]

  Progesterone

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Progesterone inhibits the expression of ABCG1 [8]

  Telmisartan

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Telmisartan increases the expression of ABCG1 [9]

  Decitabine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Decitabine affects the expression of ABCG1 [10]

  Lindane

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Lindane increases the expression of ABCG1 [11]

  Cidofovir

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cidofovir inhibits the expression of ABCG1 [12]

  Ibuprofen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ibuprofen increases the expression of ABCG1 [12]

  Ifosfamide

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ifosfamide inhibits the expression of ABCG1 [12]

  Tamoxifen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tamoxifen increases the expression of ABCG1 [13]

  Obeticholic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Obeticholic acid inhibits the expression of ABCG1 [14]

  Acetaminophen

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Acetaminophen increases the expression of ABCG1 [15]

  Potassium perchlorate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Potassium perchlorate inhibits the expression of ABCG1 [16]

  Dronabinol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dronabinol inhibits the expression of ABCG1 [17]

  Nicotine polacrilex

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nicotine polacrilex inhibits the expression of ABCG1 [18]

  Sunitinib

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Sunitinib increases the expression of ABCG1 [19]

  Rifampin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Rifampin increases the expression of ABCG1 [20]

  Valproic Acid

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Valproic Acid increases the expression of ABCG1 [21]

  Cyclosporine

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cyclosporine increases the expression of ABCG1 [22]

  Estradiol

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Estradiol increases the expression of ABCG1 [23]

Regulation Mechanism

via enhancement of Oxysterols receptor LXR-alpha (NR1H3) Transcription Factor Info

Affected Drug/Substrate

Cholesterol Modulation Type Inducer

Cell System

C57BL/6 mice vascular smooth muscle cells

  Tretinoin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tretinoin increases the expression of ABCG1 [24]

Regulation Mechanism

via enhancement of Oxysterols receptor LXR-alpha (NR1H3) Transcription Factor Info

Affected Drug/Substrate

Cholesterol Modulation Type Inducer

Cell System

Mouse macrophage cells (J774A1)

  Cisplatin

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cisplatin increases the expression of ABCG1 [25]

Regulation Mechanism

via enhancement of Homeobox protein Hox-B13 (HOXB13) Transcription Factor Info

Affected Drug/Substrate

Cisplatin Modulation Type Inducer

Cell System

Human lung adenocarcinoma isolates

Drug Marketed but not Approved by US FDA

  Linoleic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Linoleic Acid inhibits the expression of ABCG1 [4]

  Clodronic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clodronic Acid inhibits the expression of ABCG1 [12]

Drug in Phase 3 Trial

  Curcumin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Curcumin increases the expression of ABCG1 [27]

Regulation Mechanism

via enhancement of Oxysterols receptor LXR-alpha (NR1H3) Transcription Factor Info

Cell System

Mouse atherosclerotic lesions

  Triclosan

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Triclosan increases the expression of ABCG1 [41]

  Epigallocatechin gallate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Epigallocatechin gallate inhibits the expression of ABCG1 [46]

Drug in Phase 2 Trial

  MS-275

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

MS-275 increases the expression of ABCG1 [35]

  Ethanol

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ethanol inhibits the expression of ABCG1 [42]

Drug in Phase 1 Trial

  Trichostatin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Trichostatin A increases the expression of ABCG1 [29]

Regulation Mechanism

via enhancement of Oxysterols receptor LXR-alpha (NR1H3) Transcription Factor Info

Cell System

ApoE deficient mice

  Palmitic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Palmitic Acid increases the expression of ABCG1 [4]

Drug in Preclinical Test

  Oleic Acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Oleic Acid inhibits the expression of ABCG1 [4]

Investigative Drug

  Arachidonic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Arachidonic acid inhibits the expression of ABCG1 [4]

  Icosapentum

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Icosapentum inhibits the expression of ABCG1 [4]

  27-hydroxycholesterol

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

27-hydroxycholesterol increases the expression of ABCG1 [20]

  CS-6969

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

CS-6969 increases the expression of ABCG1 [32]

  Tributyltin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tributyltin increases the expression of ABCG1 [11]

Patented Pharmaceutical Agent

  TO-901317

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

TO-901317 increases the expression of ABCG1 [26]

Regulation Mechanism

via enhancement of Oxysterols receptor LXR-alpha (NR1H3) Transcription Factor Info

Cell System

Chinese hamster ovary epithelial cells (CHO)

  GW-3965

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GW-3965 increases the expression of ABCG1 [28]

Regulation Mechanism

via enhancement of Oxysterols receptor LXR-alpha (NR1H3) Transcription Factor Info

Cell System

Human alveolar macrophages

  GSK-J4

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

GSK-J4 increases the expression of ABCG1 [39]

Natural Product

  Tobacco Smoke Pollution

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tobacco Smoke Pollution increases the expression of ABCG1 [45]

  Resveratrol

           7 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Coumestrol co-treated with Resveratrol results in decreased expression of ABCG1 mRNA [49]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

PPARG protein promotes the reaction Resveratrol results in increased expression of ABCG1 mRNA [82]

Regulation Mechanism

Transcription Factor Info

  DT Modulation3

Resveratrol results in increased activity of ABCG1 protein [83]

Regulation Mechanism

Transcription Factor Info

  DT Modulation4

Resveratrol results in increased expression of ABCG1 mRNA [84]

Regulation Mechanism

Transcription Factor Info

  DT Modulation5

Resveratrol results in increased expression of ABCG1 protein [63]

Regulation Mechanism

Transcription Factor Info

  DT Modulation6

Resveratrol results in increased expression of ABCG1 protein which results in increased secretion of Cholesterol [63]

Regulation Mechanism

Transcription Factor Info

  DT Modulation7

ZM 241385 inhibits the reaction Resveratrol results in increased expression of ABCG1 protein [82]

Regulation Mechanism

Transcription Factor Info

Dietary Constituent

  Stearic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Stearic acid increases the expression of ABCG1 [4]

Environmental toxicant

  Zinc

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Zinc increases the expression of ABCG1 [33]

  Diazinon

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Diazinon increases the expression of ABCG1 [11]

Mycotoxins

  Aflatoxin B1

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Aflatoxin B1 inhibits the expression of ABCG1 [37]

  DT Modulation2

Aflatoxin B1 results in decreased methylation of ABCG1 intron [52]

Regulation Mechanism

Transcription Factor Info

  aflatoxin B2

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

aflatoxin B2 results in increased methylation of ABCG1 intron [52]

Regulation Mechanism

Transcription Factor Info

  ochratoxin A

           2 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

ochratoxin A metabolite results in decreased expression of ABCG1 mRNA [11]

Regulation Mechanism

Transcription Factor Info

  DT Modulation2

ochratoxin A results in decreased expression of ABCG1 mRNA [11]

Regulation Mechanism

Transcription Factor Info

Acute Toxic Substance

  Mercury

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Mercury increases the expression of ABCG1 [30]

  Nickel chloride

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nickel chloride increases the expression of ABCG1 [31]

  Ochratoxin A

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Ochratoxin A inhibits the expression of ABCG1 [11]

Carcinogen

  Benzo(a)pyrene

           3 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Benzo(a)pyrene inhibits the expression of ABCG1 [43]

  Cadmium

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cadmium Chloride results in increased abundance of Cadmium which results in increased expression of ABCG1 mRNA [59]

Regulation Mechanism

Transcription Factor Info

  Nickel

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Nickel results in decreased expression of ABCG1 mRNA [75]

Regulation Mechanism

Transcription Factor Info

Fungicide

  Triadimefon

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Triadimefon increases the expression of ABCG1 [36]

  Tebuconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Tebuconazole inhibits the expression of ABCG1 [40]

  tebuconazole

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

tebuconazole results in decreased expression of ABCG1 mRNA [40]

Regulation Mechanism

Transcription Factor Info

Pesticide/Insecticide

  Cypermethrin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Cypermethrin inhibits the expression of ABCG1 [34]

  Clothianidin

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Clothianidin inhibits the expression of ABCG1 [38]

Health and Environmental Toxicant

  Perfluorooctane sulfonic acid

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Perfluorooctane sulfonic acid increases the expression of ABCG1 [22]

  Dibutyl Phthalate

           1 DT Activity Modulations Related to This Exogenous Factor Click to Show/Hide the Full List

  DT Modulation1

Dibutyl Phthalate inhibits the expression of ABCG1 [44]
References
1 PPAR-gamma pathways attenuate pulmonary granuloma formation in a carbon nanotube induced murine model of sarcoidosis. Biochem Biophys Res Commun. 2018 Sep 5;503(2):684-690.
2 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72.
3 Molecular mechanisms of action of angiopreventive anti-oxidants on endothelial cells: microarray gene expression analyses. Mutat Res. 2005 Dec 11;591(1-2):198-211.
4 Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis. 2007 Mar;191(1):11-21.
5 Histamine H4 receptor agonists have more activities than H4 agonism in antigen-specific human T-cell responses. Immunology. 2007 Jun;121(2):266-75.
6 In-vivo effects of simvastatin and rosuvastatin on global gene expression in peripheral blood leucocytes in a human inflammation model. Pharmacogenet Genomics. 2008 Feb;18(2):109-20.
7 Combining simvastatin with the farnesyltransferase inhibitor tipifarnib results in an enhanced cytotoxic effect in a subset of primary CD34+ acute myeloid leukemia samples. Clin Cancer Res. 2009 May 1;15(9):3076-83.
8 Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
9 Telmisartan ameliorates lipopolysaccharide-induced innate immune response through peroxisome proliferator-activated receptor-Gamma activation in human monocytes. J Hypertens. 2012 Jan;30(1):87-96.
10 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003.
11 Transcriptome-based functional classifiers for direct immunotoxicity. Arch Toxicol. 2014 Mar;88(3):673-89.
12 Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
13 Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR) Gamma-DEPENDENT MECHANISM. J Biol Chem. 2016 Aug 12;291(33):16977-89.
14 Pharmacotoxicology of clinically-relevant concentrations of obeticholic acid in an organotypic human hepatocyte system. Toxicol In Vitro. 2017 Mar;39:93-103.
15 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
16 Changes in trophoblasts gene expression in response to perchlorate exposition. Toxicol In Vitro. 2018 Aug;50:328-335.
17 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89.
18 Placental mechanism of prenatal nicotine exposure-reduced blood cholesterol levels in female fetal rats. Toxicol Lett. 2018 Oct 15;296:31-38.
19 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761.
20 PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J Lipid Res. 2007 Feb;48(2):373-84.
21 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
22 Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells. Arch Toxicol. 2020 May;94(5):1673-1686.
23 17beta-estradiol promotes cholesterol efflux from vascular smooth muscle cells through a liver X receptor -dependent pathway. Int J Mol Med. 2014 Mar;33(3):550-8.
24 Retinoic acid induces macrophage cholesterol efflux and inhibits atherosclerotic plaque formation in apoE-deficient mice. Br J Nutr. 2015 Aug 28;114(4):509-18.
25 HOXB13 networking with ABCG1/EZH2/Slug mediates metastasis and confers resistance to cisplatin in lung adenocarcinoma patients. Theranostics. 2019 Apr 6;9(7):2084-2099.
26 Regulation of central nervous system cholesterol homeostasis by the liver X receptor agonist TO-901317. Neurosci Lett. 2007 Aug 9;423(1):47-52.
27 Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Mol Nutr Food Res. 2012 May;56(5):691-701.
28 The role of the liver X receptor in chronic obstructive pulmonary disease. Respir Res. 2013 Oct 12;14(1):106.
29 Enhancing PPARgamma by HDAC inhibition reduces foam cell formation and atherosclerosis in ApoE deficient mice. Pharmacol Res. 2020 Oct;160:105059.
30 Microarray analysis of mercury-induced changes in gene expression in human liver carcinoma (HepG2) cells: importance in immune responses. Int J Environ Res Public Health. 2006 Jun;3(2):141-73.
31 The contact allergen nickel triggers a unique inflammatory and proangiogenic gene expression pattern via activation of NF-kappaB and hypoxia-inducible factor-1alpha. J Immunol. 2007 Mar 1;178(5):3198-207.
32 Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma SH-SY5Y cells. Mol Neurodegener. 2009 Jan 6;4:1.
33 Genomic analysis, cytokine expression, and microRNA profiling reveal biomarkers of human dietary zinc depletion and homeostasis. Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):20970-5.
34 Successful validation of genomic biomarkers for human immunotoxicity in Jurkat T cells in vitro. J Appl Toxicol. 2015 Jul;35(7):831-41.
35 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
36 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
37 Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma. Toxicology. 2016 Mar 28;350-352:31-9.
38 The neonicotinoid insecticide Clothianidin adversely affects immune signaling in a human cell line. Sci Rep. 2017 Oct 18;7(1):13446.
39 Inhibition of histone H3K27 demethylases selectively modulates inflammatory phenotypes of natural killer cells. J Biol Chem. 2018 Feb 16;293(7):2422-2437.
40 The azole fungicide tebuconazole affects human CYP1A1 and CYP1A2 expression by an aryl hydrocarbon receptor-dependent pathway. Food Chem Toxicol. 2019 Jan;123:481-491.
41 Transcriptome and DNA Methylome Dynamics during Triclosan-Induced Cardiomyocyte Differentiation Toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
42 Prenatal ethanol exposure-induced a low level of foetal blood cholesterol and its mechanism of IGF1-related placental cholesterol transport dysfunction. Toxicology. 2019 Aug 1;424:152237.
43 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297.
44 Di-n-butyl phthalate promotes lipid accumulation via the miR200c-5p-ABCA1 pathway in THP-1 macrophages. Environ Pollut. 2020 Sep;264:114723.
45 Integration of transcriptome analysis with pathophysiological endpoints to evaluate cigarette smoke toxicity in an in vitro human airway tissue model. Arch Toxicol. 2021 May;95(5):1739-1761.
46 Integrated transcriptomic and metabolomic analyses to characterize the anti-cancer effects of (-)-epigallocatechin-3-gallate in human colon cancer cells. Toxicol Appl Pharmacol. 2020 Aug 15;401:115100.
47 An induction in hepatic HDL secretion associated with reduced ATPase expression. Am J Pathol. 2009;175(4):1777-87.
48 2,2',4,4'-Tetrabromodiphenyl Ether (PBDE 47) Selectively Stimulates Proatherogenic PPAR Gamma Signatures in Human THP-1 Macrophages to Contribute to Foam Cell Formation. Chem Res Toxicol. 2022 Jun 20;35(6):1023-1035.
49 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
50 Mechanistic profiling of the cAMP-dependent steroidogenic pathway in the H295R endocrine disrupter screening system: new endpoints for toxicity testing. Toxicol Lett. 2012;208(2):174-84.
51 High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A. 2011;108(5):2058-63.
52 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018;121:214-223.
53 The human ABCG1 gene: identification of LXR response elements that modulate expression in macrophages and liver. J Lipid Res. 2005;46(10):2151-67.
54 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017;27(7):537-543.
55 Transcriptional study after Beauvericin and Enniatin B combined exposure in Jurkat T cells. Food Chem Toxicol. 2019 Aug;130:122-129.
56 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017;8(1):1369-1391.
57 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019;11(1):138.
58 Toxicogenomics-based identification of mechanisms for direct immunotoxicity. Toxicol Sci. 2013 Oct;135(2):328-46.
59 Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. Toxicology. 2022;470:153153.
60 Evaluation of Cd-induced cytotoxicity in primary human keratinocytes. Hum Exp Toxicol. 2024;43:9603271231224458.
61 Identification of potential target genes of ROR-alpha in THP1 and HUVEC cell lines. Exp Cell Res. 2017;353(1):6-15.
62 Dataset on transcriptomic profiling of cholestatic liver injury induced by food additives and a cosmetic ingredient. Data Brief. 2021;38:107373.
63 Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor gamma activation. Int J Mol Med. 2010;25(5):729-34.
64 Disulfiram suppresses growth of the malignant pleural mesothelioma cells in part by inducing apoptosis. PLoS One. 2014;9(4):e93711.
65 Cordycepin activates AMP-activated protein kinase (AMPK) via interaction with the 1 subunit. J Cell Mol Med. 2014;18(2):293-304.
66 High-Throughput Transcriptomics of Nontumorigenic Breast Cells Exposed to Environmentally Relevant Chemicals. Environ Health Perspect. 2024;132(4):47002.
67 Association between Organophosphate Ester Exposure and Insulin Resistance with Glycometabolic Disorders among Older Chinese Adults 60-69 Years of Age: Evidence from the China BAPE Study. Environ Health Perspect. 2023;131(4):47009.
68 The DCMU Herbicide Shapes T-cell Functions By Modulating Micro-RNA Expression Profiles. Front Immunol. 2022;13:925241.
69 Pharmacogenomics variation in drug metabolizing enzymes and transporters in relation to docetaxel toxicity in Lebanese breast cancer patients: paving the way for OMICs in low and middle income countries. OMICS. 2013;17(7):353-67.
70 Ovarian steroids, mitogen-activated protein kinases, and/or aspartic proteinases cooperate to control endometrial remodeling by regulating gene expression in the stroma and glands. Endocrinology. 2010;151(9):4515-26.
71 Transforming growth factor beta1 targets estrogen receptor signaling in bronchial epithelial cells. Respir Res. 2018 Aug 30;19(1):160.
72 The liver X receptors and sterol regulatory element binding proteins alter progesterone secretion and are regulated by human chorionic gonadotropin in human luteinized granulosa cells. Mol Cell Endocrinol. 2018;473:124-135.
73 Inhibition of progesterone production in human luteinized granulosa cells treated with LXR agonists. Mol Hum Reprod. 2007 Jun;13(6):373-9.
74 PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo. Sci Rep. 2024;14(1):328.
75 Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol. 2014;134(2):362-72.
76 A multi-omics approach to elucidate okadaic acid-induced changes in human HepaRG hepatocarcinoma cells. Arch Toxicol. 2024;98(9):2919-2935.
77 Ozone-derived Oxysterols Affect Liver X Receptor (LXR) Signaling: A POTENTIAL ROLE FOR LIPID-PROTEIN ADDUCTS. J Biol Chem. 2016;291(48):25192-25206.
78 Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes. Toxicology. 2015;333:53-62.
79 Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human. PLoS One. 2009;4(8):e6796.
80 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
81 Genomic and proteomic analysis of the inhibition of synthesis and secretion of aldosterone hormone induced by quinocetone in NCI-H295R cells. Toxicology. 2016;350-352:1-14.
82 Resveratrol mediates anti-atherogenic effects on cholesterol flux in human macrophages and endothelium via PPAR Gamma and adenosine. Eur J Pharmacol. 2013 Jan 5;698(1-3):299-309.
83 Resveratrol modulates ATPase activity of liposome-reconstituted ABCG1. FEBS Lett. 2013;587(15):2359-63.
84 Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochem Biophys Res Commun. 2006 Sep 29;348(3):1047-54.
85 High-throughput, quantitative assessment of the effects of low-dose silica nanoparticles on lung cells: grasping complex toxicity with a great depth of field. BMC Genomics. 2015;16(1):315.
86 Indications for distinct pathogenic mechanisms of asbestos and silica through gene expression profiling of the response of lung epithelial cells. Hum Mol Genet. 2015;24(5):1374-89.
87 DMSA-Coated Iron Oxide Nanoparticles Greatly Affect the Expression of Genes Coding Cysteine-Rich Proteins by Their DMSA Coating. Chem Res Toxicol. 2015;28(10):1961-74.
88 Screening of House Dust from Chinese Homes for Chemicals with Liver X Receptors Binding Activities and Characterization of Atherosclerotic Activity Using an in Vitro Macrophage Cell Line and [Formula: see text] Mice. Environ Health Perspect. 2019 Nov;127(11):117003.
89 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020;386:114828.
90 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20.
91 L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines. Toxicol Lett. 2010 Feb 15;192(3):408-18.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.